3-FMC Stats & Data

• Identity/Isomer confusion: 3-FMC (meta‑fluoro) is distinct from 4‑FMC (flephedrone); vendors and user reports have historically mixed these—obtain analytical confirmation where possible. • Severe market mislabeling across cathinones is currently common; drug-checking services have repeatedly found 3‑MMC samples to contain more potent stimulants like NEP or α‑PVP—start with an allergy test dose and get products checked. • Very caustic to nasal mucosa: user reports consistently describe intense burn and lingering rhinitis; rotate nostrils, finely crush, consider oral ROA to reduce damage. • Cardiovascular strain (tachycardia, hypertension) and peripheral vasoconstriction can occur; avoid overheating, heavy exertion, and hot environments; take cooling breaks and monitor for chest pain or cold, numb extremities. • Hydration: sip small amounts of water with electrolytes; avoid both dehydration and overhydration. • Sleep deprivation and redosing escalate risk for panic, paranoia, compulsive behavior; pre‑plan a hard stop time and secure sleep support (non‑alcoholic). • Avoid stacking with other serotonergic agents (especially MAOIs and tramadol); if on prescription antidepressants, expect blunted effects and increased unpredictability. • Use an accurate milligram scale; do not eyeball powders. • Rectal/IV routes can magnify potency/risks; avoid injecting RC stimulants due to unknown impurities and high harm profile. • Space sessions widely (minimum several weeks) to allow mood/monoamines to recover and to reduce reinforcement.